Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Donskov, F.; Motzer, R. J.; Voog, E.; Hovey, E. J.; Grüllich, C.; Nott, L. M.; Cuff, K. E.; Gil, T.; Jensen, N. V.; Chevreau, C.; Negrier, S.; Depenbusch, R.; Bergmann, L.; Cornelio, I.; Champsaur, A.; Escudier, B. J.; Pal, S. K.; Powles, T.; Choueiri, T. K. |
| Abstract Title: | Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 256s |
| Language: | English |
| ACCESSION: | WOS:000411931702078 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.4578 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4578 -- Source: Wos |
